PREDICTING COMPLETE CYTOGENETIC RESPONSE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH RECOMBINANT INTERFERON-ALPHA

被引：0
|
作者：
MAHON, FX
MONTASTRUC, M
FABERES, C
REIFFERS, J
机构：
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3592 / 3594
页数：3
相关论文
共 50 条
  • [21] RESTORATION OF NONCLONAL HEMATOPOIESIS IN CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALPHA
    EGERT, G
    KANZ, L
    LOHR, GW
    FAUSER, AA
    BLUT, 1990, 60 (05): : 282 - 286
  • [22] Pericarditis during interferon-alpha therapy in chronic myelogenous leukemia
    Fava, S
    Luoni, M
    Stioui, S
    HAEMATOLOGICA, 1996, 81 (05) : 484 - 484
  • [23] RECOMBINANT HUMAN INTERFERON-ALPHA INDUCED CYTOREDUCTION IN CHRONIC MYELOGENOUS LEUKEMIA - RESULTS OF A MULTICENTER STUDY
    WERTER, M
    DEWITTE, R
    JANSSEN, J
    DEPAUW, B
    HAANEN, C
    BLUT, 1988, 56 (05): : 209 - 212
  • [24] INTERFERON-ALPHA IS AN ACTIVE THERAPEUTIC AGENT IN CHRONIC MYELOGENOUS LEUKEMIA
    KOYAMA, S
    SHIBATA, A
    ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (08): : 1602 - 1610
  • [25] INTERSTITIAL PNEUMONIA CAUSED BY INTERFERON-ALPHA IN CHRONIC MYELOGENOUS LEUKEMIA
    YUFU, Y
    YAMASHITA, S
    NISHIMURA, J
    NAWATA, H
    HIRATA, J
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (03) : 253 - 253
  • [26] Interferon-alpha therapy for chronic myelogenous leukemia during pregnancy
    Kuroiwa, M
    Gondo, H
    Ashida, K
    Kamimura, T
    Miyamoto, T
    Niho, Y
    Tsukimori, K
    Nakano, H
    Ohga, S
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 59 (01) : 101 - 102
  • [27] Increase in peripheral B lymphocytes is associated with cytogenetic improvement by interferon-alpha in chronic myelogenous leukemia.
    Setoyama, M
    Tojo, A
    Tani, K
    Asano, S
    BLOOD, 1999, 94 (10) : 279B - 279B
  • [28] HEMATOLOGICAL AND GENETIC FINDINGS IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH RECOMBINANT INTERFERON-ALPHA-2
    GASTL, G
    LEITER, E
    AULITZKY, W
    TILG, H
    VONLUTTICHAU, I
    RAPP, U
    HUBER, C
    BLUT, 1986, 53 (03): : 236 - 236
  • [29] Cost-effectiveness of interferon-alpha as maintenance therapy in chronic myelogenous leukemia - Response
    Kattan, MW
    Beck, JR
    ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) : 664 - 665
  • [30] A potential mechanism for the resistance of interferon-alpha treatment in chronic myelogenous leukemia patients.
    Henderson, Y
    Deisseroth, AB
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A232 - A232
12345